Literature DB >> 21128870

FUS/TLS gene mutations are the second most frequent cause of familial ALS in the Spanish population.

Enrique Syriani1, Miguel Morales, Josep Gamez.   

Abstract

Our objective was to investigate the prevalence of FUS/TLS mutations in a Catalan familial ALS cohort undergoing a mutational study for SOD1 in 2006. We screened 25 probands from non-SOD1 families for FUS/TLS mutations. We identified two FALS probands with FUS/TLS mutations. One carried a C-to-T transition at nucleotide position 1561 (c.1561C>T) producing a p.R521C sequence change at protein level. The phenotype was characterized by a young age at onset (38.2 years old), proximal limb girdle weakness, predominant lower motor neuron signs and dropped head. Survival time ranged from 10 to 36 months. Obligate asymptomatic carriers were detected. Our second ALS6 pedigree carried a C-to-T transition at nucleotide position 1528 (c.1528G>A) producing a p.K510E sequence change at protein level. The phenotype was of an early onset (<40 years old), predominant lower motor neuron disease with short survival (nine months). In conclusion, these are the first two FUS/TLS mutations identified in Spain. The prevalence of this form of FALS (8%) is similar to the Dutch and British populations. FUS/TLS mutations are the second most common cause of FALS in our population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128870     DOI: 10.3109/17482968.2010.539235

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  7 in total

Review 1.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

2.  Expression of human FUS protein in Drosophila leads to progressive neurodegeneration.

Authors:  Yanbo Chen; Mengxue Yang; Jianwen Deng; Xiaoping Chen; Ye Ye; Li Zhu; Jianghong Liu; Haihong Ye; Yan Shen; Yan Li; Elizabeth J Rao; Kazuo Fushimi; Xiaohong Zhou; Eileen H Bigio; Marsel Mesulam; Qi Xu; Jane Y Wu
Journal:  Protein Cell       Date:  2011-07-12       Impact factor: 14.870

3.  Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.

Authors:  Alexandra Arenas; Jing Chen; Lisha Kuang; Kelly R Barnett; Edward J Kasarskis; Jozsef Gal; Haining Zhu
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

4.  PFN1 mutations are also rare in the Catalan population with amyotrophic lateral sclerosis.

Authors:  Enrique Syriani; Candi Salvans; Maria Salvadó; Miguel Morales; Laura Lorenzo; Sonia Cazorla; Josep Gamez
Journal:  J Neurol       Date:  2014-09-24       Impact factor: 4.849

5.  Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis.

Authors:  Jing Ma; Xiaomin Pang; Shan Huang; Jing Zhang; Juan Wang; Rongjuan Zhao; Xueli Chang; Junhong Guo; Wei Zhang
Journal:  Neurol Sci       Date:  2021-09-26       Impact factor: 3.830

6.  Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.

Authors:  Lihua Hou; Bin Jiao; Tingting Xiao; Lu Zhou; Zhifan Zhou; Juan Du; Xinxiang Yan; Junling Wang; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

7.  ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation.

Authors:  Andrew King; Claire Troakes; Bradley Smith; Matthew Nolan; Olimpia Curran; Caroline Vance; Christopher E Shaw; Safa Al-Sarraj
Journal:  Acta Neuropathol Commun       Date:  2015-10-09       Impact factor: 7.578

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.